ReviewEffect of anti-epileptic drug therapy on the unborn child
Section snippets
Background
Antiepileptic drugs (AED) in pregnancy are associated with an increased risk of foetal malformations (FM). This has been documented by studies dating from the 1970s related to the traditional AED and more recently from prospective studies [1].
Due to lack of prospective data and adequate numbers, not enough is known of the new AED but it appears that they are no more teratogenic than the traditional ones. A significant period of time, perhaps a decade, needs to elapse before any long-term
The burden of epilepsy
Patients with epilepsy are concerned about the risk of seizures and resultant injuries, restrictions on driving and alcohol, and employment discrimination, but the greatest concern for a pregnant woman with epilepsy is the unborn child.
Three questions are often posed. Will the baby inherit epilepsy? Will the baby be physically normal? And will the baby be normal in terms of mental and emotional development? The third question is particularly complex. Answers to the first two questions may
Pregnancy registers
Registers were established in the late 1990s in order to undertake observational studies, based on Ethics Committee approval, informed consent and voluntary participation. Their ethical basis has been soundly affirmed by Sevulescu [20]. Registers comprise the North American, European International Registry of Antiepileptic Drugs and Pregnancy (EURAP), Danish, British and Australian registers, which collaborate closely. Their similarities and differences have been published [21], [22], [23], [24]
Polytherapy considerations and folate supplementation
In spite of conservative teaching on the merits of monotherapy in the treatment of epilepsy, about 25% of patients report exposure to more than one AED. As the number of possible AED combinations is high, the exploration of the teratogenicity of AED combinations has been infrequently undertaken [6], although it remains a fertile field for study.
The concept that polytherapy is inherently more teratogenic than monotherapy has been challenged in recent reports, suggesting that it is the content of
Teratogenicity of individual AED
Individual AED and FM were the subject of an excellent review by Eadie [1].
New or second generation AED
All new AED were initially designed to treat partial epilepsy. Effective and specific drugs for the treatment of genetic generalised epilepsy are sadly lacking. Over time, the approvals for lamotrigine (LTG), topiramate (TPM) and levetiracetam were extended to include genetic generalised epilepsy.
Data accrued for use in monotherapy are less robust for these drugs than for traditional drugs, as they were used as add-on treatments in many countries.
Among live-born infants in Denmark, first
Cognitive developmental defects and AED exposure
The collaborative NEAD study represents a major landmark initiative, reporting prospective results and extensive investigations of children exposed to AED in pregnancy [55]. There are several excellent reports arising out of this project. Its key findings are very important because of the implication that neurodevelopmental dysfunction may be even more devastating than many of the physical malformations resulting from AED exposure in utero. The findings of this study cause concern and are
Overview and conclusions
Prospective studies are needed to obtain valid data on questions related to foetal exposure to AED. Pregnancy registers can be used to study aspects besides teratogenicity of AED. All AED are teratogenic to a variable degree when compared to untreated WWE.
Dose issues are important particularly for VPA, as high doses are responsible for both physical FM and cognitive defects, affecting IQ and language [56], [57], [58].
A suggested upper VPA dose limit is 400 to 700 mg per day in divided doses, but
Conflicts of Interest/Disclosures
The authors declare that they have no financial or other conflicts of interest in relation to this research and its publication.
Acknowledgments
I wish to thank my colleagues, M.J. Eadie, T.J. O’Brien, C.M. Lander, A. Wood, and the Coordinator of the Australian Pregnancy Register, J. Graham. Thanks also to T. Tomson and the EURAP Central Project Commission, D. Battino, E. Bonizzoni, J. Craig, D. Lindhout, E. Perucca and A. Sabers.
References (58)
- et al.
Congenital malformations due to antiepileptic drugs
Epilepsy Res
(1999) - et al.
The teratogenic effect of carbamazepine: a meta-analysis of 1255, exposures
Reprod Toxicol
(2002) - et al.
Teratogenicity of valproic acid
J Paediatr
(1980) - et al.
Maternal epilepsy and abnormalities of the fetus and newborn
Lancet
(1972) - et al.
In utero exposure to valproate and neural tube defects
Lancet
(1986) - et al.
Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry
Lancet Neurol
(2011) - et al.
Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy
J Clin Neurosci
(2004) - et al.
Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts
Epilepsy Res
(2008) - et al.
The Australian antiepileptic drug in pregnancy register: aspects of data collection and analysis
J Clin Neurosci
(2007) - et al.
The Internal control group in a register of antiepileptic drug use in pregnancy
J Clin Neurosci
(2008)
Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate
Seizure
The teratogenic effect of carbamazepine: a meta analysis of 1255 exposures
Reprod Toxicol
Possible teratogenic effect of valproic acid
J Paediatr
Lamotrigine plasma levels reduced by oral contraceptives
Epilepsy Res
Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register
Seizure
Levetiracetam monotherapy during pregnancy: case series
Epilepsy Behav
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD Study): a prospective observational study
Lancet Neurol
Antiepileptic drugs as human teratogens
Expert Opin Drug Saf
Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy
Epilepsia
Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine)
Epilepsia
The teratogenicity of anticonvulsant drugs
N Engl J Med
Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register
J Neurol Neurosurg Psychiatry
Foetal malformations and seizure control: 52 months data of the Australian, Pregnancy Register
Eur J Neurol
Seizure control in antiepileptic drug-treated pregnancy
Epilepsia
Pregnancy treatment guidelines. Throwing the baby out with the bathwater
Epilepsia
Increased rate of major malformations in offspring exposed to valproate during pregnancy
Neurology
Should valproate be taken during pregnancy?
Ther Clin Risk Manage
Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth
J Med Genet
Cited by (12)
Influence of perfluorocarbons on Carbamazepine and Benzodiazepine for a neuro-lung protective strategy
2017, Journal of Clinical NeuroscienceCitation Excerpt :Lennox-Gastaut type of seizures that affects the Central Nervous System (CNS), are facing drug administration problems. Control of seizures is difficult [1–5]. An unexpected disharmony in seizures results in epilepsy.
My profile in epilepsy
2017, Epilepsy and BehaviorInteractions between hormonal contraception and antiepileptic drugs: Clinical and mechanistic considerations
2015, SeizureCitation Excerpt :Combined oral contraceptives (COCs) and AEDs can interact bi-directionally, resulting in possible therapeutic failure of either treatment, which may lead to unintended pregnancy and/or increased seizure activity. Contraceptive failure is a disaster for all women, but is particularly critical for women with epilepsy (WWE) owing to the teratogenic potential of the AEDs and other adverse effects on the developing child [1,2]. Unfortunately, contraceptive failure in women using AEDs is disturbingly common [3].
An evaluation of a human stem cell line to identify risk of developmental neurotoxicity with antiepileptic drugs
2015, Toxicology in VitroCitation Excerpt :The targets for AEDs also mediate a range of physiological processes in the developing brain and therefore their use can impact neurodevelopment (Costa et al., 2004). Consistent with this notion, epidemiological studies show that AEDs during pregnancy are associated with an increased risk of fetal malformations including neural tube defects, growth retardation and microcephaly (Gedzelman and Meador, 2012; Meador et al., 2013; Tomson et al., 2011; Vajda, 2014). Moreover, in utero exposure in humans to AEDs increases the risk of cognitive dysfunction in later life (Meador et al., 2013) and in animals can damage domains critical for learning, memory and attention in the developing brain (Ikonomidou and Turski, 2010; Shi et al., 2010; Wu and Wang, 2002).
Antiepileptics
2015, Side Effects of Drugs AnnualCitation Excerpt :Of note, direct correlation cannot be inferred from the above findings. However, the authors did note that the correlation may be stronger with spina bifida than hypospadias because 85% of spina bifida cases were associated with valproic acid [155c]. A case of pediatric valproate toxicity was reported for a 2-year-old female admitted for accidental ingestion of 4-grams of sodium valproate (330 mg/kg).
Adverse fetal and neonatal outcomes following in-utero exposure to oxcarbazepine: A systematic review and meta-analysis
2022, British Journal of Clinical Pharmacology